Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus
The SLE-001 study randomized 42 patients who were diagnosed with lupus at least six months before and had a baseline SELENA-SLEDAI score greater than or equal to four. Participants were randomized ......
